Peripheral neuropathies and anti-glycolipid antibodies
The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Abstract
This review charts the progress of anti-glycolipid antibodies in neuropathy, from their original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through to current discoveries mapping their relationship to subtypes of Guillain-Barré syndrome. Antibodies to >20 different glycolipids have now been associated with a wide range of clinically identifiable acute and chronic neuropathy syndromes. Particular progress has been achieved in understanding the link between acute motor axonal neuropathy and antibodies to GM1, GD1a, GM1b and GalNAc-GD1a, and between the cranial, bulbar and sensory variants of GBS and antibodies to the disialylated gangliosides GQ1b, GT1a, GD1b and GD3. In addition to clinical and serological studies, the origins and measurement of anti-glycolipid antibodies and their relationships to similar carbohydrate structures on infectious organisms, particularly Campylobacter jejuni, are discussed in the context of a molecular mimicry hypothesis. The structure and nomenclature of relevant glycolipids are outlined, along with information on their localization in nerve, and the influence this has on clinical phenotypes. Major advances have been made in animal modelling of anti-glycolipid antibody-associated diseases, both in vitro and in vivo. This has advanced our understanding of the role of anti-GQ1b antibodies in Miller Fisher syndrome with particular respect to the motor nerve terminal as a potential site of injury, and led to the creation of rabbit models of anti-GD1b and anti-GM1 antibody-mediated sensory and motor neuropathy, respectively. With such information in place, it will now be possible to determine the precise mechanisms by which antibodies injure the different compartments of peripheral nerve and establish how a range of immunomodulating therapies, including current treatments, exert their therapeutic effects. Despite these very significant advances, considerable gaps in our knowledge persist, and it is likely that other pathogenic pathways operate in inflammatory neuropathy that are unrelated to glycolipid antibodies, although these are outside the scope of this review.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complementfi xing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990 -991).”
From Biological roles of glycans (2017) · cites this paper as [990]
Citations
Cites
Items 201–296 of 296
Kanda, T. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.1.235 · Cited by 66
Schluep, M., & Steck, A. J. (1988) · Neurology · doi:10.1212/wnl.38.12.1890 · Cited by 65
Buchwald, B., Weishaupt, A., Toyka, K. V., & Dudél, J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12155-2 · Cited by 64
Destruction of Mammalian Motor Nerve Terminals by Black Widow Spider Venom
Okamoto, M., Longenecker, H. E., Riker, W. F., & Song, S. K. (1971) · Science · doi:10.1126/science.172.3984.733 · Cited by 64
Ritz, M., Lechner‐Scott, J., Scott, R. J., Fuhr, P., Malik, N., Erne, B., Taylor, V., Suter, U., Schaeren‐Wiemers, N., & Steck, A. J. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00250-7 · Cited by 63
Ataxic polyneuropathy and anti-Pr2 IgM? M proteinemia
Arai, M., Yoshino, H., Kusano, Y., Yazaki, Y., Ohnishi, Y., & Miyatake, T. (1992) · Journal of Neurology · doi:10.1007/bf00833915 · Cited by 63
Yuki, N., Miyatani, N., Sato, S., Hirabayashi, Y., Yamazaki, M., Yoshimura, N., Hayashi, Y., & Miyatake, T. (1992) · Neurology · doi:10.1212/wnl.42.3.686 · Cited by 61
Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy
Carpo, M., Pedotti, R., Lolli, F., Pitrola, A., Allaria, S., Scarlato, G., & Nobile‐Orazio, E. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00312-2 · Cited by 61
Fisher Syndrome with tetraparesis and antibody to GQ1b: Evidence for motor nerve terminal block
Uncini, A., & Lugaresi, A. (1999) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199905)22:5<640::aid-mus14>3.0.co;2-# · Cited by 61
O’Hanlon, G. M., Paterson, G. J., Veitch, J., Wilson, G., & Willison, H. J. (1998) · Acta Neuropathologica · doi:10.1007/s004010050847 · Cited by 60
Self-citationInduction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides
Wirguin, I., Briani, C., Šuturkova, L., Fisher, T., Della‐Latta, P., Chaliff, P., & Latov, N. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00095-7 · Cited by 60
Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain–Barré syndrome
Mori, M., Kuwabara, S., Miyake, M., Dezawa, M., Adachi-Usami, E., Kuroki, H., Noda, M., & Hattori, T. (1999) · Neurology · doi:10.1212/wnl.52.6.1282 · Cited by 59
O’Hanlon, G. M., Veitch, J., Gallardo, E., Illa, I., Chancellor, A. M., & Willison, H. J. (2000) · Autoimmunity · doi:10.3109/08916930008994083 · Cited by 59
Self-citationTaki, T., & Ishikawa, D. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2247 · Cited by 58
Factors affecting the fine specificity and sensitivity of serum antiganglioside antibodies in ELISA
Ravindranath, M. H., Ravindranath, R. M. H., Morton, D. L., & Graves, M. C. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90270-4 · Cited by 57
Guillain–Barré syndrome associated with IgG monospecific to ganglioside GD1b
Miyazaki, T., Kusunoki, S., Kaida, K.-I., Shiina, M., & Kanazawa, I. (2001) · Neurology · doi:10.1212/wnl.56.9.1227 · Cited by 55
The neuromuscular junction of the mouse after black widow spider venom.
Duchen, L. W., Gomez, S., & Queiroz, L. S. (1981) · The Journal of Physiology · doi:10.1113/jphysiol.1981.sp013787 · Cited by 55
Yuki, N., Handa, S., Tai, T., Takahashi, M., SAITO, K., Tsujino, Y., & Taki, T. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00045-4 · Cited by 53
Lopate, G., Parks, B. J., Goldstein, J. M., Yee, W.-C., Friesenhahn, G. M., & Pestronk, A. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.6.581 · Cited by 53
Monoclonal Proteins in Neuropathy
Kyle, R. A. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30205-6 · Cited by 53
Neisser, A., Bernheimer, H., Berger, T., Moran, A. P., & Schwerer, B. (1997) · Infection and Immunity · doi:10.1128/iai.65.10.4038-4042.1997 · Cited by 52
Experimental Induction of Myelin Changes by Anti-MAG Antibodies and Terminal Complement Complex
MONACO, S., FERRARI, S., BONETTI, B., MORETTO, G., KIRSHFINK, M., NARDELLI, E., NOBILE-ORAZIO, E., ZANUSSO, G., RIZZUTO, N., & TEDESCO, F. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199501000-00012 · Cited by 52
Koga, M., Yuki, N., & Hirata, K. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.4.513 · Cited by 52
Obi, T., Kusunoki, S., Takatsu, M., Mizoguchi, K., & Nishimura, Y. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb05069.x · Cited by 51
O’Hanlon, G. M., Paterson, G. J., Wilson, G., Doyle, D., McHardie, P., & Willison, H. J. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199602000-00007 · Cited by 51
Self-citationAntiglycolipid antibodies in peripheral neuropathy: fact or fiction?
Willison, H. J. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.11.1303 · Cited by 51
Self-citationKohriyama, T., Ariga, T., & Yu, R. K. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01823.x · Cited by 51
Guillain-Barré syndrome after exogenous gangliosides in Italy.
Landi, G., D’Alessandro, R., Dossi, B. C., Ricci, S., Simone, I. L., & Ciccone, A. (1993) · BMJ · doi:10.1136/bmj.307.6917.1463 · Cited by 48
NOSOLOGICAL ENTITIES?: Bickerstaff's encephalitis and the Miller Fisher syndrome
Winer, J. B. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.4.433 · Cited by 48
Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome
Ilyas, A. A., Mithen, F. A., Chen, Z.-W., & Cook, S. D. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90095-o · Cited by 46
Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome
Yako, K., Kusunoki, S., & Kanazawa, I. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00174-4 · Cited by 46
Hirakawa, M., McCabe, J. T., & Kawata, M. (1992) · Cell and Tissue Research · doi:10.1007/bf00319364 · Cited by 45
Kashihara, K., Shiro, Y., KOGA, M., & Yuki, N. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.5.799 · Cited by 45
Ang, C. W., Endtz, H. P., Jacobs, B. C., Laman, J. D., de Klerk, M. A., van der Meché, F. G. A., & van Doorn, P. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00279-9 · Cited by 44
Immunological parameters in Guillain-Barr� syndrome
McFarlin, D. E. (1990) · Annals of Neurology · doi:10.1002/ana.410270708 · Cited by 44
Chapter 22 Antibodies to glycoconjugates in neuropathy and motor neuron disease
Latov, N. (1994) · Progress in brain research · doi:10.1016/s0079-6123(08)61957-3 · Cited by 43
The Role of Glycosphinglipids in Neurological Disorders: Mechanisms of Immune Actiona
YU, R. K., & ARIGA, T. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09682.x · Cited by 42
Monoclonal IgM Cold Agglutinins with Anti-Pr(1d) Specificity in a Patient with Peripheral Neuropathy
Herron, B. M., Willison, H. J., Veitch, J., Roelcke, D., Illis, L. S., & Boulton, F. E. (1994) · Vox Sanguinis · doi:10.1111/j.1423-0410.1994.tb05039.x · Cited by 42
Self-citationIgG anti-GQ1b positive acute ataxia without ophthalmoplegia
Mori, M., Kuwabara, S., Koga, M., Asahina, M., Ogawara, K., Hattori, T., & Yuki, N. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.5.668 · Cited by 41
The spectrum of antecedent infections in Guillain-Barré syndrome, a case-control study
Jacobs, B. C., Rothbarth, P. (., Meche, F., Herbrink, P. (., Schmitz, P., de Klerk, M., & van Doorn, P. A. (1998) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 41
Ohsawa, T., Miyatake, T., & Yuki, N. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90728-4 · Cited by 40
A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1
Zielasek, J., Ritter, G., Magi, S., Hartung, H., & Toyka, K. V. (1994) · Journal of Neurology · doi:10.1007/bf00919708 · Cited by 40
Motoneuron-disease-like disorder after ganglioside therapy
Scarlato, G., Nobile‐Orazio, E., Yuki, N., Sato, S., Miyatake, T., Sugiyama, K., Katagiri, T., & Sasaki, H. (1991) · The Lancet · doi:10.1016/0140-6736(91)90453-v · Cited by 40
IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls.
Bansal, A. S., Abdul-Karim, B., Malik, R. A., Goulding, P., Pumphrey, R. S. H., Boulton, A. J. M., Holt, P. J. L., & Wilson, P. B. (1994) · Journal of Clinical Pathology · doi:10.1136/jcp.47.4.300 · Cited by 37
Gangliosides and Guillain-Barré syndrome
Raschetti, R., Maggini, M., Popoli, P., Caffari, B., Cas, R. D., Menniti‐Ippolito, F., Alegiani, S. S., & Traversa, G. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00557-9 · Cited by 36
Ataxic form of Guillain-Barre syndrome associated with anti-GD1b IgG antibody
Yuki, N., Susuki, K., & Hirata, K. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.1.136 · Cited by 36
Familial Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis
Yuki, N., & Tsujino, Y. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70539-2 · Cited by 34
Kusunoki, S., Chiba, A., Hirabayashi, Y., Irie, F., Kotani, M., Kawashima, I., Tai, T., & Nagai, Y. (1993) · Brain Research · doi:10.1016/0006-8993(93)90013-d · Cited by 33
Maeda, Y., Bigbee, J. W., Maeda, R., Miyatani, N., Kalb, R. G., & Yu, R. K. (1991) · Experimental Neurology · doi:10.1016/0014-4886(91)90178-f · Cited by 32
IUPAC‐IUB Commission on Biochemical Nomenclature (CBN)
(1970) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1970.tb00812.x · Cited by 31
Monosialoganglioside (GM1) immunofluorescence in rat spinal roots studied with a monoclonal antibody
Molander‐Melin, M., Berthold, C., Persson, H., Andersson, K., & Fredman, P. (1997) · Journal of Neurocytology · doi:10.1023/a:1018571711014 · Cited by 30
Matsumoto, A., Yoshino, H., Yuki, N., Hara, Y., Cashman, N. R., Handa, S., & Miyatake, T. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00101-7 · Cited by 30
Degeneration of rabbit sensory neurons induced by passive transfer of anti-GD1b antiserum
Kusunoki, S., Hitoshi, S., Kaida, K., Murayama, S., & Kanazawa, I. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00621-7 · Cited by 29
Variants of the Guillain Barr� syndrome: Progress Toward Fulfilling ?Koch's postulates?
Sheikh, K. A., & Griffin, J. W. (2001) · Annals of Neurology · doi:10.1002/ana.1057 · Cited by 28
Koga, M., Yuki, N., Ariga, T., & Hirata, K. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00331-1 · Cited by 28
Govoni, V., Granieri, E., Tola, M. R., Paolino, E., Casetta, I., Fainardi, E., & Monetti, V. C. (1997) · Brain · doi:10.1093/brain/120.7.1123 · Cited by 28
Derrington, E. A., & Borroni, E. (1990) · Developmental Brain Research · doi:10.1016/0165-3806(90)90228-q · Cited by 25
Coma and brain stem areflexia in brain stem encephalitis (Fisher's syndrome).
Al-Din, A. S. N., Jamil, A. S., & Shakir, R. A. (1985) · BMJ · doi:10.1136/bmj.291.6494.535 · Cited by 25
Differential expression of gangliosides on the surfaces of myelinated nerve fibers
Ganser, A. L., & Kirschner, D. A. (1984) · Journal of Neuroscience Research · doi:10.1002/jnr.490120212 · Cited by 25
Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barr� syndrome
Jacobs, B. C., Meulstee, J., van Doorn, P. A., & van der Mech�, F. G. A. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199704)20:4<446::aid-mus7>3.0.co;2-a · Cited by 25
Campylobacter jejuni infection and Guillain-Barré syndrome.
Fujimoto, S., Fujiita, M., & Kojima, F. (2000) · Cited by 24
Pestronk, A., Choksi, R. M., Yee, W.-C., Kornberg, A. J., Lopate, G., & Trotter, J. L. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00182-9 · Cited by 23
Kitazawa, K., Tagawa, Y., Honda, A., & Yuki, N. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00020-3 · Cited by 23
ELISA-type titertray assay of IgM anti-GM1 autoantibodies
Bech, E., Jakobsen, J., & Orntoft, T. F. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.7.1331 · Cited by 20
Inuzuka, T., Miyatani, N., Baba, H., Tanaka, M., Tanaka, K., Sato, S., Nakamura, K., & Miyatake, T. (1988) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1988.tb03619.x · Cited by 20
Younes‐Chennoufi, A. B., Meininger, V., Léger, J., Bouché, P., Jauberteau, M., & Baumann, N. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90049-w · Cited by 20
Correlation between cytomegalovirus infection and IgM anti‐MAG/SGPG antibody–associated neuropathy
Yuki, N., Yamamoto, T., & Hirata, K. (1998) · Annals of Neurology · doi:10.1002/ana.410440321 · Cited by 19
Fisher's syndrome associated with chickenpox and anti-GQ1b antibody
Takano, H., & Yuki, N. (1995) · Journal of Neurology · doi:10.1007/bf00919603 · Cited by 19
Effect of m7G5′ppp5′Nm on the rabbit globin synthesis
Suzuki, H. (1977) · FEBS Letters · doi:10.1016/0014-5793(77)80339-6 · Cited by 19
Guijo, C. G., García-Merino, A., Rubio, G., Guerrero, A. M. A., Martínez, A. C., & Arpa, J. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90165-h · Cited by 18
Ogawa‐Goto, K., Kubota, K., Kurotani, A., & Abe, T. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90146-5 · Cited by 18
Hitoshi, S., Kusunoki, S., Murayama, S., Tsuji, S., & Kanazawa, I. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00985-9 · Cited by 18
Fine specificities of anti-LM1 IgG antibodies in Guillain-Barré syndrome
Susuki, K., Yuki, N., Hirata, K., & Kuwabara, S. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00005-9 · Cited by 18
IUPAC‐IUB Commission on Biochemical Nomenclature (CBN): Recommendations, 1976*
(1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb11990.x · Cited by 18
Yuki, N., Miyatake, T., Ichihashi, Y., Sato, S., & Katagiri, T. (1992) · PubMed · Cited by 17
Mesencephalitis and Rhombencephalitis
Pickworth, F. A. (1951) · BMJ · doi:10.1136/bmj.2.4727.362-a · Cited by 16
Muscle fiber conduction velocity in arg1239his mutation in hypokalemic periodic paralysis
Links, T. P., & van der Hoeven, J. H. (2000) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(200002)23:2<164::aid-mus4>3.0.co;2-y · Cited by 14
Rees, J. H., Gregson, N. A., & Hughes, R. A. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.2.605 · Cited by 14
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome
Ho, T. W., Willison, H. J., Nachamkin, I., Li, C. Y., Veitch, J., Ung, H., Wang, G. R., Liu, R. C., Cornblath, D. R., Asbury, A. K., et al. (1999) · ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · doi:10.1002/1531-8249(199902)45:2<168::aid-ana6>3.0.co;2-6 · Cited by 13
Self-citationA monoclonal antibody that recognizes ganglioside GD1b in the rat central nervous system
Maehara, T., Ono, K., Tsutsui, K., Watarai, S., Yasuda, T., Inoue, H., & Tokunaga, A. (1997) · Neuroscience Research · doi:10.1016/s0168-0102(97)00068-0 · Cited by 12
Tagawa, Y., Irie, F., Hirabayashi, Y., & Yuki, N. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00005-2 · Cited by 11
Acute isolated ophthalmoplegia as a variant of Miller-Fisher syndrome
Sakurai, Y., Mannen, T., & Kusunoki, S. (1998) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199808)21:8<1107::aid-mus26>3.0.co;2-p · Cited by 11
Nobile‐Orazio, E., Meucci, N., Baldini, L., Troia, A., & Scarlato, G. (2000) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2000.22-14.x · Cited by 11
Infection by Mycoplasma pneumoniae induces serum antibody against Gal-C.
Kusunoki, S., Takizawa, H., & Kanazawa, I. (1996) · PubMed · Cited by 9
Oldfors, A. (1986) · Cellular and Molecular Life Sciences · doi:10.1007/bf02118636 · Cited by 8
Nobile‐Orazio, E., Meucci, N., Baldini, L., et al. (2000) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2000.00022-14.x · Cited by 8
The Spectrum and Pathogenesis of Antibody-mediated Neuropathies
Quarles, R. H. (1997) · The Neuroscientist · doi:10.1177/107385849700300313 · Cited by 7
Senda, T., Sugimoto, N., Horiguchi, Y., & Matsuda, M. (1995) · Toxicon · doi:10.1016/0041-0101(94)00165-5 · Cited by 7
Ritz, M., Lechner‐Scott, J., Rj, S., et al. (2000) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2000.00022-13.x · Cited by 7
Lunn, M. P., Muir, P., Brown, L. J., MacMahon, E. M. E., Gregson, N. A., & Hughes, R. A. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2<267::aid-ana20>3.0.co;2-m · Cited by 7
Ritz, M., Lechner‐Scott, J., Scott, R. J., Fuhr, P., Malik, N. S., Erne, B., Taylor, V., Suter, U., Schaeren‐Wiemers, N., Steck, et al. (2000) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2000.22-13.x · Cited by 7
No cytomegalovirus DNA in sera from patients with anti-MAG/SGPG antibody-associated neuropathy
Irie, S., Kanazawa, N., Ogino, M., Saito, T., & Funato, T. (2000) · Annals of Neurology · Cited by 6
Solano (2000) · doi:10.1002/1531-8249(200002)47:2 · Cited by 3
Jacobs, B. C., Hazenberg, M. (., van Doorn, P. A., Endtz, H. P., & Meche, F. (1997) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complement-fixing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990, 991).”
BackgroundHughes, R. A., & Cornblath, D. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67665-9 · Cited by 1,676
Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00339-1 · Cited by 1,609
Self-citationGuillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B. C., & van Doorn, P. A. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.121 · Cited by 1,101
Irani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
“, 2009) as clearly demonstrated, for instance, in patients with Guillain–Barré syndrome (Willison and Yuki, 2002).”
Metadata
- Authors
- Willison, H. J.
- Affiliations
- Southern General Hospital (GB)
- Corresponding author
- Willison, H. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12-01
- Volume
- 125
- Issue
- 12
- Pages
- 2591-2625
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2021949020
- Cited by
- 710
- References
- 286
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 19 · 2023: 22 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 12 · 2018: 20 · 2017: 23 · 2016: 34 · 2015: 30 · 2014: 37 · 2013: 32 · 2012: 33
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- anti-glycolipid antibodies, peripheral neuropathy, Guillain-Barré syndrome, Miller Fisher syndrome, acute motor axonal neuropathy, gangliosides, GM1, GD1a, GQ1b, Campylobacter jejuni, molecular mimicry, sensory neuropathy, immunomodulatory therapy
- MeSH terms
- Animals, Autoantibodies, Glycolipids, Humans, Immunoglobulin G, Immunoglobulin M, Peripheral Nervous System Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.